Dorinem Injection

About Dorinem 500 mg/vial Injection

Dorinem 500 mg/vial Injection is a hospital antibiotic made by Advanced Chemical Industries PLC. It contains doripenem, a carbapenem-type antibacterial given by intravenous infusion for certain serious bacterial infections.

What is Dorinem 500 mg/vial Injection?

Dorinem 500 mg/vial Injection is produced by Advanced Chemical Industries PLC and contains doripenem, a broad-spectrum carbapenem antibiotic that belongs to the beta-lactam group. It works by blocking the building of the bacterial cell wall, which stops bacteria from growing. It is given by intravenous infusion in a hospital or clinic setting, not as a tablet at home. Doctors use it only when an infection is proven or strongly suspected to be caused by bacteria that respond to it, and culture and sensitivity information is taken into account where available. The dose, course and duration are decided by the treating doctor.

Uses of Dorinem

Dorinem Injection is used for certain serious bacterial infections, including complicated intra-abdominal infections and complicated urinary tract infections such as pyelonephritis. It is also used in patients with infection in the blood alongside these conditions. It is not meant to treat every infection, and it is not intended for treating any type of pneumonia. The doctor decides whether it is suitable after assessing the infection and, where possible, culture and sensitivity results. Ask the doctor about the reason it has been prescribed.

How to use Dorinem

Dorinem Injection is given by intravenous infusion over a set period, prepared and administered by a doctor or nurse in a hospital or clinic. It is not for use at home by the patient. The dose, the interval between doses and the length of the course are decided by the doctor, and may be adjusted in people with reduced kidney function. Tell the doctor about all other medicines being taken, and do not stop or change the course on your own.

Side effects of Dorinem

Side effects that may occur with Dorinem Injection include headache, nausea, diarrhoea, rash, itching, inflammation of the vein at the infusion site, raised liver enzymes, oral thrush, anaemia, low platelet count, low white cell count and fungal vaginal infection. Some people may have an allergic reaction. Tell the doctor or nurse promptly about any new or troublesome symptom during or after treatment, especially rash, swelling or breathing difficulty.

Safety and precautions

Dorinem Injection should not be used by anyone with a known allergy to doripenem, other carbapenems, or a history of serious allergic reaction to beta-lactam antibiotics such as penicillins or cephalosporins. People with known or suspected brain or nervous system disorders, including a history of seizures, and people with reduced kidney function need careful assessment. The doctor should be told about pregnancy, breastfeeding and all medicines being taken, including probenecid and valproic acid. Kidney function and signs of allergy may be checked; ask the doctor about any concerns before treatment.

Frequently asked questions

What is the price of Dorinem 500 mg/vial Injection?

The listed price is ৳ 2006.00.

What does the generic name doripenem mean?

Doripenem is the generic name of the active ingredient in Dorinem Injection. It is a carbapenem, a type of beta-lactam antibiotic that acts against many bacteria. The generic name identifies the medicine itself, while Dorinem is the brand made by Advanced Chemical Industries PLC.

What is Dorinem Injection used for and what kind of medicine is it?

It is an antibiotic given by intravenous infusion for certain serious bacterial infections, such as complicated intra-abdominal infections and complicated urinary tract infections including pyelonephritis. It is not intended for treating any type of pneumonia. The doctor decides whether it suits the infection.

Is Dorinem Injection safe in pregnancy or breastfeeding?

It is classed as pregnancy category B, meaning animal studies did not show a confirmed risk in the first trimester, but there are no controlled studies in pregnant women. It is not known to be free of risk. Tell the doctor if you are pregnant, planning pregnancy or breastfeeding so the doctor can decide.

Indications

To reduce the development of drug-resistant bacteria and maintain the effectiveness of Doripenem and other antibacterial drugs, Doripenem should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are ... Read moreTo reduce the development of drug-resistant bacteria and maintain the effectiveness of Doripenem and other antibacterial drugs, Doripenem should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting and modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.

Complicated Intra-Abdominal Infections: Doripenem injection is indicated as a single agent for the treatment of complicated intra-abdominal infections caused by Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Bacteroides caccae, Bacteroides fragilis, Bacteroides thetaiotaomicron, Bacteroides uniformis, Bacteroides vulgatus, Streptococcus intermedius, Streptococcus constellatus and Peptostreptococcus micros.

Complicated Urinary Tract Infections, Including Pyelonephritis: Doripenem injection is indicated as a single agent for the treatment of complicated urinary tract infections, including pyelonephritis caused by Escherichia coli including cases with concurrent bacteremia, Klebsiella pneumoniae, Proteus mirabilis, Pseudomonas aeruginosa and Acinetobacter baumannii.

Pharmacology

Doripenem is a synthetic broad-spectrum carbapenem β-lactam antibiotic with potent in vitro antibacterial activity against aerobic and anaerobic gm+ve and gm-ve bacteria including Pseudomonas aeruginosa. It inhibits bacterial cell wall synthesis by binding to several penicillin-binding proteins, which in turn inhibits the final transpeptidase step of peptidoglycan synthesis in bacterial cell walls.

Dosage & Administration

Intravenous-
  • Complicated intra-abdominal infections: 500 mg 8 hrly infused over 1 hr for 5-14 days. May switch to an appropriate oral therapy, after at least 3 days of parenteral therapy.
  • Complicated UTI, Pyelonephritis: 500 mg 8 hrly infused over 1 hr for 10 days. May switch to an appropriate oral therapy, after at least 3 days of parenteral therapy.
  • Patient with concurrent bacteraemia: Duration can be extended up to 14 days.
Renal impairment-
  • CrCI (30-50 ml/min): 250 mg every 8 hr by IV infusion over 1 hr
  • CrCI (11 -29 ml/min): 250 mg every 12 hr by IV infusion over 1 hr

Interaction

Increased plasma concentration with probenecid. May decrease plasma levels of valproic acid thus, increasing the risk of seizures.

Contraindications

Hypersensitivity to doripenem, other carbapenem antibacterial agents; history of anaphylactic reaction to β-lactams (e.g. penicillins, cephalosporins).

Side Effects

Headache, nausea, diarrhoea, rash, pruritus, phlebitis, elevated hepatic enzymes, oral candidiasis, anaemia, vulvomycotic infection, thrombocytopenia, neutropenia.

Pregnancy & Lactation

Pregnancy Category B. Either animal-reproduction studies have not demonstrated a fetal risk but there are no controlled studies in pregnant women or animal-reproduction studies have shown an adverse effect (other than a decrease in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is no evidence of a risk in later trimesters).

Precautions & Warnings

Patient with known or suspected CNS disorders (e.g. brain lesions, history of seizures). Not intended for treatment of any type of pneumonia. Renal impairment. Pregnancy and lactation. Monitoring Parameters Monitor renal function and for signs of anaphylaxis during 1st dose. Consider haematologic assessment during prolonged therapy.

Storage Conditions

Reconstituted suspension may be held for 1 hr prior to dilution in infusion bag. Following dilution of the suspension with NaCl 0.9%, stability is 8 hr at room temperature or 24 hr between 2-8°C. Stability of solution when diluted with dextrose 5% injection is 4 hr at room temperature or 24 hr between 2-8°C.

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.